Total solutions for Tuberculosis Diagnostics
- USTAR has been deeply engaged in the field of tuberculosis diagnostics for nearly 20 years, dedicated to developing precise, rapid, and widely applicable automated standardized testing technologies. This meets patients’ expectations for instant and accurate diagnosis and treatment, while supporting healthcare institutions in achieving high-quality and sustainable development. It also responds to national calls to improve the positive detection rate of bacterial pathogens and to strengthen diagnostic capabilities at the primary care level.
- Currently, USTAR has developed a comprehensive end-to-end TB diagnostic solution, covering TB vs. non-TB differentiation, TB drug resistance detection, and NTM typing, with performance highly consistent in head-to-head comparisons with Xpert Ultra.
- MultNAT MTB/RIF has been selected through the Foundation for Innovative New Diagnostics (FIND) global evaluation process and has passed laboratory performance assessments in South Africa.
Key features of USTAR TB Molecular POC Tests
- Rapid and accurate detection of TB using nucleic acid technology.
- Ideal for decentralized testing and point-of-care settings.
- Portable device with user-friendly interface.
- Differentiates between Mycobacterium tuberculosis complex (MTC) and non-tuberculous mycobacteria (NTM).
- Provides rapid identification of species for targeted treatment.
- Simultaneous detection of TB and rifampicin (RIF) resistance, a key marker for multidrug-resistant TB (MDR-TB).
- Accurate identification of RIF-resistant strains in one test.
- Available High-throughput and scalable solution for laboratory settings.
